Stocks · Health care · Pharmaceutical Preparations

Organon & Co.

OGN Clue Score37
United States Fiscal year ends December CIK 0001821825 Results filed 30 Apr 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kevin Ali
Chief Executive Officer
—
—
—
282,731
$3.84M
+82.0%
Matthew M Walsh
Chief Financial Officer
—
—
—
212,746
$2.89M
+129.7%
Joseph T. Morrissey Jr.
Interim CEO
—
—
—
123,123
$1.67M
+153.3%
Rachel A Stahler
Chief Information Officer
—
—
—
116,105
$1.58M
+101.6%
Aaron Falcione
Chief Human Resources Officer
—
—
—
101,431
$1.38M
+173.9%
Kirke Weaver
Gen. Counsel & Corp. Secy.
—
—
—
92,639
$1.26M
+198.9%
Carrie Smith Cox
Executive Chair
—
—
—
90,338
$1.23M
+624.5%
Vittorio Nisita
Head of Global Business Svcs
—
—
—
70,619
$958.30K
+151.1%
Daniel Karp
Executive VP, Corp. Dev.
—
—
—
69,548
$943.77K
+245.9%
Lynette Holzbaur
SVP and Corporate Controller
—
—
—
52,851
$717.19K
+386.7%
Kathryn DiMarco
Corporate Controller
—
—
—
38,740
$525.70K
+66.0%
Ferreira Juan Camilo Arjona
Head of R&D & CMO
—
—
—
37,432
$507.96K
—
Juliana Papa Drinane
Head of Mfg & Supply
—
—
—
18,475
$250.70K
+50.1%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.